One elevated blood eosinophil count is enough to identify mepolizumab responders in chronic obstructive pulmonary disease.

Ramakrishnan S

Open source

DOI
10.1093/ajrccm/aamag352
Published
2026 Sep 1
Container
American journal of respiratory and critical care medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajrccm/aamag352,
  title = {One elevated blood eosinophil count is enough to identify mepolizumab responders in chronic obstructive pulmonary disease.},
  author = {Ramakrishnan S},
  year = {2026},
  journal = {American journal of respiratory and critical care medicine},
  doi = {10.1093/ajrccm/aamag352},
  url = {https://doi.org/10.1093/ajrccm/aamag352}
}

RIS

TY  - JOUR
TI  - One elevated blood eosinophil count is enough to identify mepolizumab responders in chronic obstructive pulmonary disease.
AU  - Ramakrishnan S
PY  - 2026
JO  - American journal of respiratory and critical care medicine
DO  - 10.1093/ajrccm/aamag352
UR  - https://doi.org/10.1093/ajrccm/aamag352
ER  - 

APA

S, R. (2026). One elevated blood eosinophil count is enough to identify mepolizumab responders in chronic obstructive pulmonary disease.. American journal of respiratory and critical care medicine. https://doi.org/10.1093/ajrccm/aamag352

Source records